Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational Study

INTRODUCTION: Patients with differentiated thyroid cancer (DTC) are treated with (near)-total thyroidectomy followed by remnant ablation. Optimal radioiodine-131 ((131)I) uptake is achieved by withholding thyroid hormone (THW), pretreatment with recombinant human Thyrotropin Stimulating Hormone (rhT...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Horst-Schrivers, Anouk N. A., Sluiter, Wim J., Muller Kobold, Anneke C., Wolffenbuttel, Bruce H. R., Plukker, John T. M., Bisschop, Peter H., de Klerk, John M., Al Younis, Imad, Lips, Paul, Smit, Jan W., Brouwers, Adrienne H., Links, Thera P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367989/
https://www.ncbi.nlm.nih.gov/pubmed/25793762
http://dx.doi.org/10.1371/journal.pone.0120184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367989/
https://www.ncbi.nlm.nih.gov/pubmed/25793762
http://dx.doi.org/10.1371/journal.pone.0120184

Ejemplares similares